MENU
IVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inventiva SA (IVA) Earnings Date & Reports

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH... Show more

A.I. Advisor
published Earnings

IVA is expected to report earnings to rise 61.57% to -37 cents per share on September 25

Inventiva SA IVA Stock Earnings Reports
Q2'26
Est.
$-0.37
Q1'26
Beat
by $0.04
Q4'25
Missed
by $0.73
Q3'25
Missed
by $0.01
Q2'25
Missed
by $1.02
The last earnings report on May 26 showed earnings per share of -23 cents, beating the estimate of -27 cents. With 997.80K shares outstanding, the current market capitalization sits at 827.81M.
View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
77
Web
https://www.inventivapharma.com